A 52-year-old woman from rural Maharashtra presents with progressive fatigue, weight gain of 8 kg over 6 months, constipation, and dry skin. She reports feeling cold even in warm weather. On examination, her heart rate is 52/min, BP 138/88 mmHg, and skin is cool and dry. Serum TSH is 18.5 mIU/L (normal 0.4–4.0), free T₄ is 0.8 ng/dL (normal 0.8–1.8). What is the most appropriate next step in management?

Explanation

## Diagnosis and Initial Management of Primary Hypothyroidism **Key Point:** This patient has overt primary hypothyroidism (elevated TSH, low-normal free T₄) with classic clinical features: fatigue, weight gain, cold intolerance, bradycardia, constipation, and dry skin. ### Why Levothyroxine 50 mcg Daily? 1. **Starting Dose Selection:** - In non-elderly, non-cardiac patients, the standard starting dose is **50 mcg daily** - 25 mcg is reserved for elderly patients (>60 years), those with cardiac disease (especially CAD), or severe hypothyroidism with cardiac complications - This 52-year-old has no contraindication to standard dosing 2. **Monitoring Interval:** - TSH should be rechecked **6–8 weeks** after initiation (not 2 weeks) - This allows steady-state serum levels to be reached (T-half of levothyroxine ≈ 7 days; steady state = 5–6 half-lives ≈ 35–42 days) - Premature rechecking leads to unnecessary dose escalations 3. **Target TSH:** - Goal TSH range is typically 0.5–2.5 mIU/L for non-pregnant, non-cardiac patients - Dose adjustments are made in 25–50 mcg increments based on TSH response **High-Yield:** The **6–8 week recheck rule** is high-yield for NEET PG — many students mistakenly recheck at 2–4 weeks. ### Why Not the Other Options? | Option | Why Incorrect | |--------|---------------| | 25 mcg daily + 2-week recheck | Suboptimal starting dose for this age/risk profile; 2-week recheck is premature (steady state not reached) | | Thyroid ultrasound first | Not indicated unless there is a nodule, asymmetry, or suspicion of malignancy; ultrasound does not change management of uncomplicated hypothyroidism | | Antibody testing before therapy | While anti-TPO/anti-thyroglobulin confirm autoimmune etiology (Hashimoto's), they do NOT alter initial treatment or dosing; can be checked after stabilization if needed | **Clinical Pearl:** In India, iodine deficiency remains a cause of hypothyroidism in endemic areas; however, once TSH is elevated, the management is identical regardless of etiology. [cite:Harrison 21e Ch 405]